Monitor resolution of the $20M impaired Specialty Finance loan over the next 2-3 quarters; the $8.8M impairment suggests potential for further charge-offs. Watch for Q4 2026 earnings for updates on credit quality and the PBCO merger timeline.
Price Chart
Executive Summary
Northrim BanCorp reported Q3 2026 adjusted EPS of $0.60, a 14.3% miss vs consensus of $0.70, driven by an $8.8M impairment on a single $20M Specialty Finance loan. Underlying core trends were strong — record net interest income of $38.9M (+10% YoY), NIMTE above 5%, and pre-provision net revenue up 21% QoQ — but the credit event overshadows the quarter and signals elevated risk in the Specialty Finance portfolio.
Key Financial Metrics
Key Facts
- Adjusted diluted EPS of $0.60 missed consensus of $0.70 by 14.3%
- Net income of $14.4M down from $27.1M in Q3 2025, driven by $7.7M provision for credit losses
- Record net interest income of $38.9M, up 10% YoY and 5% QoQ
- NIMTE of 5.02%, up 14 bps YoY
- Pre-provision pre-tax net revenue of $26.5M, up 21% QoQ
- Specialty Finance segment posted a net loss of $4.3M due to $8.8M impairment on a $20M loan
- Nonperforming assets net of guarantees surged to $42.9M from $23.0M in Q2 2026
- Allowance for credit losses on loans at 82% of nonperforming loans, down from 117% in Q2
- Merger with PBCO Financial Corporation expected to close in Q1 2027
Financial Impact
EPS miss of $0.10 vs consensus; $8.8M impairment on a single $20M Specialty Finance loan; net income down $12.7M YoY
Risk Factors
- Further deterioration in the Specialty Finance loan portfolio could lead to additional provisions
- PBCO merger integration risks and potential dilution from all-stock transaction
- Elevated nonperforming assets at 1.20% of total assets may pressure credit ratings
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3382205 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $24.20 | awaiting T+60 | — | $23.74 (−1.90%) |
Oct 22, 2026 4d ago | Press Release | $24.20 | awaiting T+60 | — | $23.74 (−1.90%) |
Oct 15, 2026 11d ago | Press Release | $23.55 | awaiting T+60 | — | $23.74 (−0.81%) |
Oct 15, 2026 11d ago | 8-K | $23.55 | awaiting T+60 | — | $23.74 (−0.81%) |
Sep 18, 2026 5w ago | EFFECT | $25.44 | awaiting T+60 | — | $23.74 (−6.68%) |
Sep 15, 2026 5w ago | S-4/A | $25.56 | awaiting T+60 | — | $23.74 (−7.12%) |
Aug 31, 2026 8w ago | Insider Cluster | $25.38 | awaiting T+60 | — | $23.74 (−6.46%) |
Aug 28, 2026 8w ago | Press Release | $25.65 | awaiting T+60 | — | $23.74 (−7.45%) |
Jul 23, 2026 13w ago | 8-K | $27.15 $24.43 | ▼ −10.02% | ▼ −14.57% | $23.74 (−12.56%) |
Jul 22, 2026 13w ago | Press Release | $27.15 $24.43 | ▼ −10.02% | ▼ −14.57% | $23.74 (−12.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers